Wela Strategies’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,921
Closed -$378K 48
2022
Q4
$378K Buy
4,921
+347
+8% +$26.4K 0.21% 32
2022
Q3
$305K Sell
4,574
-690
-13% -$43.7K 0.21% 34
2022
Q2
$275K Buy
5,264
+67
+1% +$3.81K 0.16% 34
2022
Q1
$295K Sell
5,197
-152
-3% -$8.14K 0.15% 35
2021
Q4
$275K Buy
5,349
+178
+3% +$8.73K 0.14% 37
2021
Q3
$256K Buy
5,171
+625
+14% +$33.9K 0.13% 37
2021
Q2
$260K Buy
4,546
+139
+3% +$8.12K 0.11% 38
2021
Q1
$268K Buy
+4,407
New +$243K 0.14% 37

Other funds holding CAH

Wela Strategies's CAH Position: Q1 2023 in Review

Wela Strategies sold out of Cardinal Health (CAH) in Q1 2023, closing a stake of 4,921 shares — an estimated $378K sold.

Wela Strategies first reported a position in CAH in Q1 2021 and held it in 8 quarters. The position peaked at $378K in Q4 2022. 907 funds tracked by Wall St. Rank hold CAH as of Q1 2023.

  • Wela Strategies reported no remaining Cardinal Health position as of Q1 2023 after selling out during the quarter.
  • Wela Strategies sold 4,921 Cardinal Health shares in Q1 2023, an estimated $378K.
  • Wela Strategies first reported a position in Cardinal Health in Q1 2021 and held it in 8 quarters.
  • Wela Strategies's Cardinal Health position peaked at $378K in Q4 2022.
  • 907 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2023.

Based on Wela Strategies's 13F filing for Q1 2023, filed 10 Apr 2023.